Fundraising Fox
AshiBio
Burlingame, US · 2 known investors
Find your way into AshiBio
Sign up to see every warm intro you have to AshiBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AshiBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
āshibio is a biotech company developing novel therapies for rare bone and connective tissue disorders, led by a team of scientists, physicians and drug developers. Its lead product is the antibody andecaliximab.
Founders & leadership
VS
Victoria SmithChief Scientific Officer
DW
Deborah WenkertChief Medical OfficerDeborah Wenkert is Chief Medical Officer of AshiBio, a biotech company developing therapies for rare bone and connective tissue disorders. She is a pediatric rheumatologist with experience in rheumatology, bone disease, and rare disorders across academic and industry settings.
JS
Joseph SarretActing Chief Operating Officer
BS
Investors · 2
Agent Capital✓ confirmed by AshiBioWaltham
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Related companies · 8
AskBioAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.
AzbioAZBio is a statewide industry association and advocate for Arizona's bioscience sector, connecting biotech, medtech, and healthcare organizations to support the state's life science ecosystem. The organization provides resources, leadership, and advocacy to establish Arizona as a top-ten life science state.
AxbioA life sciences company offering nanopore sequencing instruments and automated library preparation systems for molecular biology research.
Akamis BioAkamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life. The company serves patients and clinicians in the oncology market.
ARTBIOARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.
AviadoBioAviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
HiFiBiO TherapeuticsHiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics. The platform supports target discovery, antibody selection, and predictive biomarker identification for drug development.
Avivo Biomedical Inc.Avivo develops enzyme-based technology to convert blood types and enable organ compatibility, increasing access to transfusions and transplants while reducing waste in healthcare systems. The company serves hospitals, transplant centers, military and emergency care settings with a platform designed to integrate into existing clinical workflows.
Companies working in the same space as AshiBio.
Frequently asked questions
- What does AshiBio do?
- āshibio is a biotech company developing novel therapies for rare bone and connective tissue disorders, led by a team of scientists, physicians and drug developers. Its lead product is the antibody andecaliximab.
- Who founded AshiBio?
- AshiBio was founded by Pankaj Bhargava.
- Who are AshiBio's investors?
- AshiBio's investors include Agent Capital, MPM BioImpact.
- Where is AshiBio headquartered?
- AshiBio is headquartered in Burlingame, US.